Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Feb 07, 2021 11:52pm
113 Views
Post# 32498079

RE:RE:RE:RE:Prospectus & Event Catalyst

RE:RE:RE:RE:Prospectus & Event Catalyst
wagyusteak wrote:
Benedict16th wrote: Fact: GUD share price are exactly where they were 7 Years ago “zero - nada  growth. Is GUD an investment grade product? How long has it been since investors got positive news? If you kept your money sleeping in cash  you would be no worst. 


Great. 12 more years to go and suddenly it becomes an overnight success. LOL


And potentially ahead of schedule.
We are in countires covering populations of 600+ million people (Canada, Mexico and South America).  We have future licensies (high revenue potential) that cover an additional1.3 billion people (Canada, Russia, Sub-Saharan Africa and Israel).
By the mid-2020s we are servicing a world community of approximately 2 billion people.

There is nothing normal about the way we get there.  But ... that's why we pay Goodman the big bucks.  As the saying goes ... the best is yet to come.

: )


<< Previous
Bullboard Posts
Next >>